164 related articles for article (PubMed ID: 20021831)
1. [Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Fang XQ
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):769-72. PubMed ID: 20021831
[TBL] [Abstract][Full Text] [Related]
2. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Shi GH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
4. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.
Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H
Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520
[TBL] [Abstract][Full Text] [Related]
5. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
6. Application of the alteration uptake ratio of
Huang Z; Lou C
Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
[TBL] [Abstract][Full Text] [Related]
7. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.
Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710
[TBL] [Abstract][Full Text] [Related]
8. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
9. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma.
Magnan H; Chou AJ; Chou JF; Yeung HW; Healey JH; Meyers PA
Cancer; 2010 Sep; 116(17):4147-51. PubMed ID: 20564163
[TBL] [Abstract][Full Text] [Related]
11. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.
Inaki A; Taki J; Wakabayashi H; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Ann Nucl Med; 2012 Aug; 26(7):545-50. PubMed ID: 22610389
[TBL] [Abstract][Full Text] [Related]
14. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
[TBL] [Abstract][Full Text] [Related]
15. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ
Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302
[TBL] [Abstract][Full Text] [Related]
17. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
18. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
20. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]